Literature DB >> 16054544

Steroid phobia and adherence--problems, solutions, impact on benefit/risk profile.

Vivek U Rao1, Andrea J Apter.   

Abstract

Adherence is important with all medications. It can be more difficult with inhaled steroids in light of concern about adverse effects. Although the degree of fear regarding inhaled steroids is difficult to quantify, it appears to be an important factor in adherence. These fears exist for several reasons, including misinformation obtained from such sources as the Internet. To improve adherence and decrease morbidity and mortality, it is vital that health care providers are aware of potential barriers to adherence. Measures such as simplifying and properly explaining medication regimens are helpful. Just as important is the establishment of a strong patient-provider relationship. This makes it easier to convince patients of the need for recommended medications. If the provider is able to effectively communicate and convince the patient of the benefit/risk ratio of steroids, improved patient outcomes can be achieved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054544     DOI: 10.1016/j.iac.2005.04.002

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  4 in total

1.  Pimecrolimus cream in the management of patients with atopic eczema.

Authors:  Jonathan M Spergel
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-05-19

2.  Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea.

Authors:  Jin Yong Lee; Young Her; Chul Woo Kim; Sang Seok Kim
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

3.  A survey of patients' perspectives of steroid injection (ppyeojusa) in Korea.

Authors:  Bo-Mi Shin; Sung Jun Hong; Yun Hee Lim; Jae Hun Jeong; Ho Sik Moon; Hey Ran Choi; Sun Kyung Park; Richard Jin Woo Han; Jae Hun Kim
Journal:  Korean J Pain       Date:  2019-07-01

4.  Fluticasone furoate nasal spray in the treatment of allergic rhinitis.

Authors:  Pedro Giavina-Bianchi; Rosana Agondi; Rafael Stelmach; Alberto Cukier; Jorge Kalil
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.